Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Impact of breast MRI in women eligible for breast conservation surgery and intra-operative radiation therapy.

Paudel N, Bethke KP, Wang LC, Strauss JB, Hayes JP, Donnelly ED.

Surg Oncol. 2018 Mar;27(1):95-99. doi: 10.1016/j.suronc.2018.01.001. Epub 2018 Jan 8.

PMID:
29549911
2.

A multi-institutional analysis of intraoperative radiotherapy for early breast cancer: Does age matter?

Abbott AM, Valente SA, Loftus L, Tendulkar RD, Greif JM, Bethke KP, Donnelly ED, Lottich C, Ross DL, Friedman NB, Bedi CG, Joh JE, Kelemen P, Hoefer RA, Kang SK, Ruffer J, Police A, Fyles A, Graves GM, Willey SC, Tousimis EA, Small W, Lyons J, Grobmyer S, Laronga C.

Am J Surg. 2017 Oct;214(4):629-633. doi: 10.1016/j.amjsurg.2017.06.018. Epub 2017 Jun 23.

PMID:
28918848
3.

Tamoxifen Acceptance and Adherence among Patients with Ductal Carcinoma In Situ (DCIS) Treated in a Multidisciplinary Setting.

Karavites LC, Kane AK, Zaveri S, Xu Y, Helenowski I, Hansen N, Bethke KP, Rasmussen-Torvik LJ, Khan SA.

Cancer Prev Res (Phila). 2017 Jul;10(7):389-397. doi: 10.1158/1940-6207.CAPR-17-0029. Epub 2017 May 30.

4.

National Evaluation of the New Commission on Cancer Quality Measure for Postmastectomy Radiation Treatment for Breast Cancer.

Minami CA, Bilimoria KY, Hansen NM, Strauss JB, Hayes JP, Feinglass JM, Bethke KP, Rydzewski NR, Winchester DP, Palis BE, Yang AD.

Ann Surg Oncol. 2016 Aug;23(8):2446-55. doi: 10.1245/s10434-016-5257-5. Epub 2016 May 11.

PMID:
27169774
5.

TARGIT-R (Retrospective): North American Experience with Intraoperative Radiation Using Low-Kilovoltage X-Rays for Breast Cancer.

Valente SA, Tendulkar RD, Cherian S, O'Rourke C, Greif JM, Bailey L, Uhl V, Bethke KP, Donnelly ED, Rudolph R, Pederson A, Summer T, Lottich SC, Ross DL, Laronga C, Loftus L, Abbott AM, Kelemen P, Hermanto U, Friedman NB, Bedi GC, Joh JE, Thompson WA 3rd, Hoefer RA, Wilson JP, Kang SK, Rosen B, Ruffer J, Bravo L, Police A, Escallon JM, Fyles AW, McCready DR, Graves GM, Rohatgi N, Eaker JA, Graves J, Willey SC, Tousimis EA, Collins BT, Shaw CM, Riley L, Deb N, Kelly T, Andolino DL, Boisvert ME, Lyons J, Small W Jr, Grobmyer SR.

Ann Surg Oncol. 2016 Sep;23(9):2809-15. doi: 10.1245/s10434-016-5240-1. Epub 2016 May 9.

PMID:
27160524
6.

Cytologic atypia in the contralateral unaffected breast is related to parity and estrogen-related genes.

Monahan DA, Wang J, Lee O, Revesz E, Taft N, Ivancic D, Hansen NM, Bethke KP, Zalles C, Khan SA.

Surg Oncol. 2016 Dec;25(4):449-456. doi: 10.1016/j.suronc.2015.12.001. Epub 2015 Dec 30.

PMID:
26856771
7.

Clinical outcomes with the MammoSite radiation therapy system: results of a prospective trial.

Small W Jr, Refaat T, Strauss JB, Gopalakrishnan M, Bethke KP, Mendelson EB, Wolfman JA, Jovanovic BD, Kiel K.

J Radiat Oncol. 2015 Dec;4(4):395-400. Epub 2015 Nov 2.

8.

Local transdermal therapy to the breast for breast cancer prevention and DCIS therapy: preclinical and clinical evaluation.

Lee O, Ivancic D, Allu S, Shidfar A, Kenney K, Helenowski I, Sullivan ME, Muzzio M, Scholtens D, Chatterton RT Jr, Bethke KP, Hansen NM, Khan SA.

Cancer Chemother Pharmacol. 2015 Dec;76(6):1235-46. doi: 10.1007/s00280-015-2848-y. Epub 2015 Nov 11.

PMID:
26560487
9.

A Multi-institutional Analysis of Insurance Status as a Predictor of Morbidity Following Breast Reconstruction.

Vieira BL, Lanier ST, Mlodinow AS, Bethke KP, Murphy RX Jr, Hume KM, Gutowski KA, Fine NA, Kim JY.

Plast Reconstr Surg Glob Open. 2014 Dec 5;2(11):e255. doi: 10.1097/GOX.0000000000000207. eCollection 2014 Nov.

10.

A randomized phase II presurgical trial of transdermal 4-hydroxytamoxifen gel versus oral tamoxifen in women with ductal carcinoma in situ of the breast.

Lee O, Page K, Ivancic D, Helenowski I, Parini V, Sullivan ME, Margenthaler JA, Chatterton RT Jr, Jovanovic B, Dunn BK, Heckman-Stoddard BM, Foster K, Muzzio M, Shklovskaya J, Skripkauskas S, Kulesza P, Green D, Hansen NM, Bethke KP, Jeruss JS, Bergan R, Khan SA.

Clin Cancer Res. 2014 Jul 15;20(14):3672-82. doi: 10.1158/1078-0432.CCR-13-3045.

11.

Individualized risk of surgical-site infection: an application of the breast reconstruction risk assessment score.

Kim JY, Khavanin N, Jordan SW, ver Halen JP, Mlodinow AS, Bethke KP, Khan SA, Hansen NM, Losken A, Fine NA.

Plast Reconstr Surg. 2014 Sep;134(3):351e-362e. doi: 10.1097/PRS.0000000000000439.

PMID:
24814422
12.

Risk factors for unplanned readmissions following excisional breast surgery.

Khavanin N, Bethke KP, Lovecchio FC, Jeruss JS, Hansen NM, Kim JY.

Breast J. 2014 May-Jun;20(3):288-94. doi: 10.1111/tbj.12253. Epub 2014 Apr 2.

PMID:
24689860
13.

Abstract 46: The BRA Score: Creating a General Risk Calculator for Breast Reconstruction Outcomes.

Khavanin N, Kim JY, Davila AA, Ver Halen JP, Mlodinow AS, Bethke KP, Khan SA, Jeruss JS, Hansen NM, Bilimoria KY, Losken A, Fine NA.

Plast Reconstr Surg. 2014 Mar;133(3 Suppl):56-7. doi: 10.1097/01.prs.0000445079.93837.65. No abstract available.

PMID:
25942157
14.

Tumescent technique does not increase the risk of complication following mastectomy with immediate reconstruction.

Khavanin N, Fine NA, Bethke KP, Mlodinow AS, Khan SA, Jeruss JS, Hansen NM, Kim JY.

Ann Surg Oncol. 2014 Feb;21(2):384-8. doi: 10.1245/s10434-013-3311-0. Epub 2013 Oct 12.

PMID:
24121881
15.

Reply: To PMID 23211118.

Gart MS, Smetona JT, Hanwright PJ, Fine NA, Bethke KP, Khan SA, Kim JY.

J Am Coll Surg. 2013 Jul;217(1):174-5. doi: 10.1016/j.jamcollsurg.2013.04.022. No abstract available.

PMID:
23791294
16.

Two surgeons, one patient: the impact of surgeon-surgeon familiarity on patient outcomes following mastectomy with immediate reconstruction.

Seth AK, Hirsch EM, Kim JY, Bethke KP, Hansen NM, Fine NA.

Breast. 2013 Oct;22(5):914-8. doi: 10.1016/j.breast.2013.04.013. Epub 2013 May 11.

PMID:
23673077
17.

Autologous options for postmastectomy breast reconstruction: a comparison of outcomes based on the American College of Surgeons National Surgical Quality Improvement Program.

Gart MS, Smetona JT, Hanwright PJ, Fine NA, Bethke KP, Khan SA, Wang E, Kim JY.

J Am Coll Surg. 2013 Feb;216(2):229-38. doi: 10.1016/j.jamcollsurg.2012.11.003. Epub 2012 Dec 2. Erratum in: J Am Coll Surg. 2013 May;216(5):1034-5.

PMID:
23211118
18.

Soy isoflavone supplementation for breast cancer risk reduction: a randomized phase II trial.

Khan SA, Chatterton RT, Michel N, Bryk M, Lee O, Ivancic D, Heinz R, Zalles CM, Helenowski IB, Jovanovic BD, Franke AA, Bosland MC, Wang J, Hansen NM, Bethke KP, Dew A, Coomes M, Bergan RC.

Cancer Prev Res (Phila). 2012 Feb;5(2):309-19. doi: 10.1158/1940-6207.CAPR-11-0251.

19.

Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer.

Bilimoria KY, Bentrem DJ, Hansen NM, Bethke KP, Rademaker AW, Ko CY, Winchester DP, Winchester DJ.

J Clin Oncol. 2009 Jun 20;27(18):2946-53. doi: 10.1200/JCO.2008.19.5750. Epub 2009 Apr 13.

PMID:
19364968
20.

Evaluating the impact of preoperative breast magnetic resonance imaging on the surgical management of newly diagnosed breast cancers.

Bilimoria KY, Cambic A, Hansen NM, Bethke KP.

Arch Surg. 2007 May;142(5):441-5; discussion 445-7.

PMID:
17515485
21.

Learning sentinel node biopsy: results of a prospective randomized trial of two techniques.

Morrow M, Rademaker AW, Bethke KP, Talamonti MS, Dawes LG, Clauson J, Hansen N.

Surgery. 1999 Oct;126(4):714-20; discussion 720-2.

PMID:
10520920
22.

Breast conservation: predictors and treatment of local recurrence.

Bethke KP.

Semin Surg Oncol. 1996 Sep-Oct;12(5):332-8. Review.

PMID:
8873321
23.

Postoperative radiotherapy improves survival in squamous cell carcinoma of the hypopharynx.

Frank JL, Garb JL, Kay S, McClish DK, Bethke KP, Lind DS, Mellis M, Slomka W, Sismanis A, Neifeld JP.

Am J Surg. 1994 Nov;168(5):476-80.

PMID:
7977979
24.

Expansion and tumour specific cytokine secretion of bryostatin-activated T-cells from cryopreserved axillary lymph nodes of breast cancer patients.

Lind DS, Tuttle TM, Bethke KP, Frank JL, McCrady CW, Bear HD.

Surg Oncol. 1993 Oct;2(5):273-82.

PMID:
8305969
25.

Activation of CD8+ murine T cells from tumor-draining lymph nodes by phorbol dibutyrate plus calcium ionophore.

Tuttle TM, Inge TH, McCrady CM, Bethke KP, Bear HD.

J Immunother (1991). 1992 Jul;12(1):32-40.

PMID:
1386251
26.

Bryostatin 1-activated T cells can traffic and mediate tumor regression.

Tuttle TM, Bethke KP, Inge TH, McCrady CW, Pettit GR, Bear HD.

J Surg Res. 1992 Jun;52(6):543-8.

PMID:
1528028
27.

Activation and growth of murine tumor-specific T-cells which have in vivo activity with bryostatin 1.

Tuttle TM, Inge TH, Bethke KP, McCrady CW, Pettit GR, Bear HD.

Cancer Res. 1992 Feb 1;52(3):548-53.

28.

Enhancement of cytotoxic T lymphocyte growth from spleens of P815-tumor-bearing host mice with mafosfamide.

Inge TH, Hoover SK, Frank JL, Kawabata TT, Bethke KP, Bear HD.

Cancer Immunol Immunother. 1992;35(2):119-26.

PMID:
1534514
29.

Diagnosis and management of sacrococcygeal chordoma.

Bethke KP, Neifeld JP, Lawrence W Jr.

J Surg Oncol. 1991 Dec;48(4):232-8. Review.

PMID:
1745047
30.

Successful long-term cryopreservation and transplantation of human fetal pancreas.

Hullett DA, Bethke KP, Landry AS, Leonard DK, Sollinger HW.

Diabetes. 1989 Apr;38(4):448-53.

PMID:
2494092
31.

Cultured human fetal pancreatic tissue reverses experimentally induced diabetes in nude mice.

Bethke KP, Hullet DA, Falany JL, Love RB, Sollinger HW.

Curr Surg. 1988 Mar-Apr;45(2):123-6. No abstract available.

PMID:
3284714

Supplemental Content

Loading ...
Support Center